Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04677881
Other study ID # 96264
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2020
Est. completion date December 31, 2020

Study information

Verified date October 2020
Source Oslo Metropolitan University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Dietary fiber is well known to have health promoting effects, including reduced blood glucose and cholesterol levels. Bread is the most important source of dietary fiber in the Norwegian diet. Production of bread has changed from the traditionally use of sourdough, to yeast (Saccharomyces cerevisiae) as the dominating leavening agent in modern industrial production. Sourdough naturally contains bacteria, and through the fermentation process these bacteria release several components that are not found in modern bread using yeast. It has been shown that sourdough may have positive health effects, including on blood glucose regulation. The aim of the project is to investigate if intake of sourdough may give positive health effects compared to beard with yeast.


Description:

The investigators aim to include approximately 20 participants in this randomized controlled double-blind cross-over study lasting for 5 weeks. All participants will be given bread baked with yeast for a 2 weeks run-in period. The participants will then be randomly assigned to either 1 week intervention with bread baked with yeast or sourdough, before a 1 week wash-out period with yeast bread. During the last 1 week intervention period the participants starting with bread baked with yeast will be given sourdough and vice versa. Questionnaires (GSRS-IBS, BSC, FFQ), blood samples, and feces samples will be collected before and after the intervention periods.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 31, 2020
Est. primary completion date December 20, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - healthy adults who restrict their intake of bread due to stomach ache. Exclusion Criteria: - Chronic metabolic diseases, such as diabetes type 1 or 2, cardiovascular diseases and cancer last 6 months - Gut diseases, including Chron's disease, ulcers colitis - Food allergies or intolerance - Pregnant and/or lactating - Smokers - BMI <18,5 and >27 kg/m2 - Planed weight reduction and/or ± 5% weight change last 3 months - Blood donor last 2 months and during the study period - Not willing to quit taking dietary supplements, including probiotics, cod liver oil etc., 4 weeks prior to study start and during the study - Use of antibiotics <3 months prior to study start and during the study - Alcohol intake >40 g/day - Hormone treatment (except contraceptives)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Intervention group
intervention group: bread with sourdough control group: bread with yeast

Locations

Country Name City State
Norway Vibeke Telle-Hansen Oslo

Sponsors (3)

Lead Sponsor Collaborator
Oslo Metropolitan University Mesterbakeren, University of Oslo

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gastrointestinal Symptom Rating Scale-irritable bowl syndrome (GSRS-IBS) GSRS-IBS analysis after intervention with bread baked with yeast versus sourdough with the following response scale: 1 (no discomfort at all) to 7 (very severe discomfort) 5 weeks
Secondary Bristol stool chart (BSC) BSC analyses after intervention with bread baked with yeast versus sourdough with a scale from 1 (separate hard lumps, like nuts) to 7 (watery, no solid pieces) 5 weeks
Secondary Blood C-peptide, total cholesterol, triglycerides, fatty acid profile, and short chain fatty acids Blood analyses of C-peptide, total cholesterol, triglycerides, fatty acid profile, and short chain fatty acids after intervention with bread baked with yeast versus sourdough 5 weeks
Secondary Feces microbiota analysis performed with Bio-Me's Precision Microbiome Profiling platform (PMP™) Feces analyses of microbiota after intervention with bread baked with yeast versus sourdough 5 weeks
Secondary Iron, selenium and zinc in blood Blood analysis of iron, selenium and zinc after intervention with bread baked with yeast versus sourdough 5 weeks
See also
  Status Clinical Trial Phase
Completed NCT02293343 - 24 Hrs Histamine Profile in Healthy Persons and Patients With Food Intolerance N/A
Completed NCT01717404 - Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C) Phase 1
Withdrawn NCT02313207 - Confocal Laser Endomicroscopy in IBS Patients N/A
Completed NCT02937506 - Patient Satisfaction With Propofol for Out Patient Colonoscopy Phase 4
Terminated NCT05579444 - Systems Biology of Gastrointestinal and Related Diseases
Completed NCT02419963 - Analyzing IBS to Identify Biomarkers and Microbiome Signatures N/A
Recruiting NCT06389851 - Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD N/A
Recruiting NCT05815602 - Ebastine Versus Mebeverine in IBS Patients Phase 3
Completed NCT03482765 - A Study of Probiotics in IBS Subjects N/A
Completed NCT03986476 - The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome N/A
Recruiting NCT06275906 - Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters. N/A
Not yet recruiting NCT05737277 - Gabapral in Pediatric IBS N/A
Active, not recruiting NCT05718505 - Comparison of the Atmo Motility Gas Capsule System to the Reference Standard N/A
Recruiting NCT06072287 - The Living With a Long-Term Condition Study
Completed NCT04953728 - Optimization of Transcutaneous Electrical Acustimulation (TEA) Modalities for Treatment of IBS-C N/A
Completed NCT02681666 - Mindfulness-Based Eating in Patients With Irritable Bowel Syndrome N/A
Completed NCT02981888 - Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
Completed NCT01667627 - Probiotic in Irritable Bowel Syndrome (IBS) Patients With Diarrhea Phase 4
Recruiting NCT01779765 - The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS) Phase 4
Completed NCT02009618 - The Effects of Rifaximin Therapy in Irritable Bowel Syndrome N/A